secwatch.observer — SEC 8-K summary
======================================

Issuer:     LEMAITRE VASCULAR INC (LMAT)
CIK:        0001158895
Form:       8-K
Filed at:   2022-07-28T23:59:59+00:00
Accession:  0001437749-22-018011
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LeMaitre Vascular Q2 sales $42.1M (+8% organic); raises FY guidance to 10% organic growth
--------------------------------------------------------------------------------

- Q2 2022 sales $42.1M (+4%, +8% organic); reported EPS $0.16 (-60%); adjusted EPS ex-special charge $0.29 (-26%).
- Operating income $5.8M (-48%); ex-$3.1M special charge from closing St. Etienne factory, op income $8.9M (-20%).
- FY 2022 guidance raised: sales $162.7M-$165.3M (mid $164M, +10% organic); op income ex-special $32.7M-$34.4M.
- Board declared $0.125 quarterly dividend, payable Sept 8 to holders of record Aug 25; $20M share repurchase program ongoing.
- Operational milestones: Seoul office opened, French factory closed, Chinese XenoSure cardiac approval filed, Omniflow II CE Mark received.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1158895/000143774922018011/0001437749-22-018011-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1158895/000143774922018011/lmat20220728_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-018011

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer